Ledger.Open graph →

SEC Form D · filed October 17, 2017

Realm Therapeutics plc

Offering

$20.5M

Sold

$20.5M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

LONDON, United Kingdom

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Matthew W. Hammond · London, United KingdomDirector Marella Thorell · London, United KingdomExec · Director Joseph W. Birkett · London, United KingdomDirector Charles Spicer · London, United KingdomDirector Alex Martin · London, United KingdomExec · Director Balkrishan W. Gill · London, United KingdomDirector Ivan W. Gergel · London, United KingdomDirector Daniel W. Hegglin · London, United KingdomDirector Ryan Powers · HALLANDALE BEACH, FLDirector Alex Martin · London, United KingdomExec · Director Ellen M. Levy · Salt Lake City, UTDirector William M. Conroy · Salt Lake City, UTDirector Alexandra Nussenbaum · HALLANDALE BEACH, FLDirector Daniel Goldsmith · Salt Lake City, UTDirector Lloyd G. Waterhouse · Salt Lake City, UTExec · Director Steven A. Collins · Salt Lake City, UTDirector Ben H. Harris · Lincoln, NEExec · Director Terry H. Dunn · Lincoln, NEDirector David M. Hadani · Lincoln, NEDirector Ken H. Hager · Lincoln, NEDirector Julie K. Hughes · Grand Cayman, Cayman IslandsDirector Brandon C. Bellamy · Accokeek, MDExec · Director Cynthia Padnos · Oakland, CADirector Matthew Mcdonagh · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗